chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt began to clear her throat & felt funny.  She continued to clear her throat more continuously.  She was given EPI @ 7:34PM, coughing/throat cleaning decreased.  Transported to Hospital, report given to (EMT) 7:37PM SpO2 100%, HR 91, BP 159/102
She had a head to toe body ache 14 hours after she got the vaccine; had fever that went up to 100.8 F; had swollen lymph node on the same arm as the injection site; full body rash; This is a spontaneous report from a contactable pharmacist (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number and expiry date were not provided), via an unspecified route of administration in arm on 11Jan2021 at single dose for COVID-19 immunization. Medical history included COVID-19 from 12Dec2020 (States that before she got the vaccine she was positive for Covid, but her positive result came back on 12Dec2020).  The patient's concomitant medications were not reported.  Caller got the COVID-19 vaccine on 11Jan2021. She had a head to toe body ache 14 hours after she got the vaccine (11Jan2021 14:00). She also had fever that went up to 100.8 Fahrenheit and had swollen lymph node on the same arm as the injection site, and a full body rash in Jan2021. She has had all these symptoms for a week now. The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
pt recv vax 21JAN97 & 1wk later pt devel a raised, pimple-like rash, which lasted approx 3 days;urine tests confirmed pregnancy (LMP 10JAN97);estimated date of delivery is 17OCT97. This is in follow-up to report (s) previously submitted on 4/16/1997, 4/15/1998. Information has been received from a physician concerning a 28-year-old female with no allergies and history of one previous pregnancy and one previous live birth, who had never had chickenpox as a child and who on 21 Jan 97, one week after her last menstrail period was vaccinated with the first dose of VARICELLA vaccine SC after having been exposed to chickenpox. One week after the vaccination, the patient developed a raised, pimple-like rash, which lasted approximately three days. The patient did not have symptoms of chickenpox or shingles after the vaccination. Subsequently, urine tests confirmed pregnancy (LMP 10 Jan 97). The estimated date of delivery is 17 Oct 97. The second dose of VARICELLA vaccine was not administered. Ultrasounds on 22 May 97 (at 18.8 weeks) and 01 Oct 97 (at 37.5 weeks) were normal. Medication during the pregnancy included prenatal vitamins. On 03 Oct 97, at 38 weeks from her LMP, the patient delivered a seven pound-five ounce normal liveborn female infant. It was noted the infant did not have any complications, congential abnormalities, chickenpox or shingles, and no features of congential varicella syndrome. No further details were provided. This is an amended report. The patient's age mpw reads 28 years instead of 29 years. "Patient recovered" was changed from unknown to yes. The narrative was updated. This report is corrected as amended.
Swelling, itching, warm, redness at (L) vast lat site. Nausea/vomiting. Sx improving at time of visit. Advised OTC hydrocortisone, oral BENADRYL if itching prevents sleep.
Pt. reports dizziness and anxiety.  Given a snack and water; observed additional 15 minutes.  Pt. felt much better, dismissed stable.
Early April 2021: began experiencing fatigue, dizziness, breathlessness, and unintended weight loss.  04/26/2021: PCP ran labs. 05/03/2021: PCP ran follow up hematology labs. 05/07/2021: Was told to admit to the hospital through the ER. 05/07/2021 - 05/11/2021 was hospitalized, tested extensively, and diagnosed with Warm Autoimmune Hemolytic Anemia. Began Prednisone, 70 mg qd. Follow up with Rheumatologist was recommended. Hemoglobin stabilized, last dose of Prednisone 09/02/2021. 10/21/2021: saw rheumatologist Dr. labs run for Lupus and Rheumatoid Arthritis due to ongoing symptoms. Dr. referred me to my immunologist due to labs reflecting low immunoglobulins both both before and after course of Prednisone.  10/27/2021: Immunologist Dr. ordered labs to test for Primary Immunodeficiency, labs taken 10/28/2021. 10/28/2021: rheumatologist noted, "Patient could meet lupus criteria today with ANA of 160, anemia, arthralgia, alopecia., however wanted to review labs done by immunologist before recommending course of treatment.
break out in a full body rash; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 23Mar2021 12:00 (Lot Number: EN6207) as SINGLE DOSE for covid-19 immunisation. The patient medical history included HIV. There were no prior vaccinations (within 4 weeks). Concomitant medication(s) included emtricitabine, tenofovir disoproxil fumarate (TRUVADA) from 2018 (reported as started 3 years ago) and ongoing taken for hiv. The patient experienced break out in a full body rash on 25Mar2021 and it was still with him. No emergency room or physician office visit. The patient was scheduled for the second dose on 19Apr2021. The outcome was not recovered.   No follow-up attempts are possible. No further information is expected.
pt recv vax 5NOV96 & called 6NOV c/o muscle pain from elbow to axilla;no redness;called 7NOV96 t102 on 6NOV;no fever 7NOV but now has 4-5" red area near inj site;8NOV fever, chills, redness upper lt arm from below inj sit to elbow;
?COVID arm?- the area around my injection site is itchy, swollen, red, and kinda bumpy under the skin.
A few weeks after first dose patient thought he had some chest pain but thought he was just imagining it; after second dose developed chest pain, doe and palpitations; ecg shows st elevations throughout; referred for echo, holter and cardiology appt
13 year old previously healthy female presenting with chest pain.  Per patient, chest pain started this AM on 6/18/21, described as substernal, pleuritic, unable to describe what it feels like. Was constant, sometimes radiating superiorly. Also reports light-headedness when standing quickly that preceded the chest pain. associated with shortness of breath. Had isolated low grade fever to 100.2 the night before, otherwise afebrile without cough, congestion, abdominal pain, N/V/D, rash, or leg swelling. Of note, patient received 2nd COVID vaccine 2 days prior to symptom onset (6/16/21).  Patient seen at Hospital, got EKG which was normal. Troponin elevated at 0.83, elevated CK 701. Was transferred for concern for myocarditis, in the setting of recent 2nd dose COVID vaccine 2 days ago. Hospital (on 6/18/21): CBC WNL. Electrolytes WNL. AST, Bili mildly elevated. ESR, CRP elevated. Troponin 19. EKG normal. COVID neg. Received Tylenol and Motrin x1.
after recv vax pt very irritable, devel rash on arms, legs, stomach, little on face- red & fine red bumps, no fever
Moderna Covid-19  vaccination doses were 100mcg; left injection site arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) and VACCINATION SITE PAIN (left injection site arm is sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 100 microgram. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) and VACCINATION SITE PAIN (left injection site arm is sore). At the time of the report, ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) had resolved and VACCINATION SITE PAIN (left injection site arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product information was provided. No Treatment Medication was provided. Patient's initial Moderna Covid-19 vaccination doses were 100mcg.   Reporter did not allow further contact
Numbness in the arm, face and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in the arm, face and shoulder) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness in the arm, face and shoulder). At the time of the report, HYPOAESTHESIA (Numbness in the arm, face and shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include a thyroid medication (unspecified).  Treatment information was not provided.
Dizziness/vertigo. Will call patient's PCP to follow up if patient needs to see the doctor or not.
OX SATURATION AS LOW AS 74, TEMPERATURE OF 100.5, DYPHORETIC, SHAKING, HOT TO TOUCH, PALE, FEELS TERRIBLE COUGHING
Started 1/9, with 1 small red spot above and below inject. site, plus a 1" diam. red spot a few inches below. Swelling under each spot. a little sore. Swelling & soreness went away in 2 days, but spots stayed.   Slight itchiness. Every day 1" spot got wider and longer.  Another elongated spot appeared. Those spots joined. No itching. Finally, 1/19, one solid area about 3"wide going from outside of arm a few inches above elbow, around to inner arm, above bend in arm. (Like "Covid Arm" I just read about.) Saw doctor on 1/20/21( My regular Dr. was unavailable. ) Recommended Benadry. Took just 1,  that evening. Next day pink area was barely visible.
Information has been received from a 17 year old female, for the Pregnancy Registry for VARIVAX (Merck), with asthma and no drug reaction who on 23-JAN-2009, "2 weeks ago Friday", was vaccinated SQ with a 0.5 ml dose of VARIVAX (Merck) when she was pregnant.  The patient did not know if she had gotten VARIVAX in the past, so she did not know if this shot was reintroduction or not.  There was no concomitant medication.  On 01-FEB-2009, at 4:00 AM, the patient noticed "a little bleeding in her underwear".  Unspecified "blood work" was performed, result not reported.  The patient did not have a physician she was seeing.  The patient was 9 weeks pregnant at the time of this report.  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/15/2009. Follow-up information has been received from another nurse-midwife in the office. It was reported that the patient has an uncomplicated pregnancy course and was induced at 41 weeks gestation for being post dates. She had a 12 hours labor and a spontaneous vaginal birth of a viable female, weighing 71 lbs. 1oz. Neither the baby nor the mother had any complications at the birth or afterwards, that she was aware of. The nurse-midwife looked at through the patient's chart prenatally and at the 6 weeks postpartum visit notes and concluded that she did not see anything to indicated there was anything abnormal for this baby or that the mother had any difficulty either. Everything seemed fine. No further information is available.
Redness and swelling at injection site; tenderness, itching, mild stinging at site.  No pox or fever.
Two days after received immunization, noticed sl. swelling, achiness. States still has pain in shoulder - radiates down to elbow & hand. (Also was cleaning out basement during this time). 8/31/2010 Patient states cleaning out basement during this timeframe due to flooding. RN advised patient to seek MD appt as possibly not TD as problem. Enc to continue to use heat/ice as needed.
Completed series about 3 months ago, last week shingles rash/ Suspected vaccination failure; Shingles rash; Neck tingling; This case was reported by a physician via call center representative and described the occurrence of vaccination failure in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (dose received years prior to the reporting). Concurrent medical conditions included peripheral neuropathy.   In May 2022, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 1st dose of Shingrix. On 23rd August 2022, 3 months after receiving Shingrix and unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and tingling. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the vaccination failure, shingles and tingling were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and tingling to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's Comment:  The reporter reported that the patient received zostavax years prior to the reporting and completed Shingrix vaccine series about 3 months prior to the reporting. The reporter stated that on last week the patient developed shingles rash and along that had neck tingling. But the physician believes neck tingling may be related to neuropathy. The reporter did not have the dates of the Shingrix vaccine doses and zostavax dose at the time of reporting as these were administered at pharmacy/drug store and not at reporter's facility. The reporter consented to follow up. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sharp pain in vaccination sight and muscle fatigue.  Pain started immediately after vaccination. Muscle fatigue noticed 2 weeks later.
Patient did not have any unusual adverse event.  This is being reported because the patient was given the vaccine using a sterile water diluent made for Merck live vaccines (NDC 000006-4309-00).  The diluent used contained sterile water 0.7ml.    The diluent should have been one containing an adjuvant that comes with the shingrix package.  The patient stated she had very minimal arm soreness.
Patient felt faint and feared passing out. Staff help patient to prone position and elevated feet. BP monitored and after ten minutes, patient returned to seat, waited another thirty minutes and left under own accord.
approximately 3 hours after vaccine, complaining of L arm pain.  Patient concerned the vaccine was placed ?too high.?  Patient reports she spoke with RN?s on her unit and showed location of vaccination and was educated it was placed too high.  Patient reports sore arm after 1st dose but reports, ?this feels so much worse.  I can barely lift my arm.?    Patient educated to rotate Tylenol and motrin according to the medical directive for prescription medication and to apply ice to injection site.  Patient educated to call vaccine support line for worsening symptoms, patient verbalized back understanding and denied further questions at this time.
Day 1-4: swollen lump, bruising  and tender to touch at the injection site Day 7: Red raised itchy rash on arm at injection site. Bruise still present
Felt bad; she was sweaty; Arm was sore; Headache; chills; fever; Achy; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (Achy), FEELING ABNORMAL (Felt bad), HYPERHIDROSIS (she was sweaty), PAIN IN EXTREMITY (Arm was sore) and HEADACHE (Headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced FEELING ABNORMAL (Felt bad). In August 2021, the patient experienced PAIN (Achy), HYPERHIDROSIS (she was sweaty), PAIN IN EXTREMITY (Arm was sore), HEADACHE (Headache), CHILLS (chills) and PYREXIA (fever). On 12-Aug-2021, PAIN (Achy), FEELING ABNORMAL (Felt bad), HYPERHIDROSIS (she was sweaty), PAIN IN EXTREMITY (Arm was sore), HEADACHE (Headache), CHILLS (chills) and PYREXIA (fever) had resolved.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Initial spontaneous report received from a nurse via Professional Information Ltd on 07 May 2010: This patient received his first dose of RABIPUR for a pre-exposure vaccination schedule three weeks prior to this report. One week after receiving RABIPUR the patient developed glandular fever. At the time of reporting the patient was still not well enough to receive the following two doses of RABIPUR. No further details were provided, and the reporter did not wish to be contacted for follow-up information.
Initial misuse report received from a healthcare professional on 13 February 2014. A 4-months-old patient (gender was not reported) had received a dose of PENTACEL and a dose of ACTHIB in 2 separate injections on the same day. No adverse event was reported. Documents held by sender: none.
mom relates fever on 10/9/99 w/rt sided body movement, then unresponsiveness;seen in ER w/unsuccessful resuscitation;
after 15 minute observation, pt complained of dizziness upon  standing, shorty after c/o of shortness of breath, chest tightness, heavinees to tongue.
Pt developed swelling, redness, induration on right thigh which worsened over course of 48 to a size of 7"L x 8"W with warmth, target center, induration. Pt given Benadryl and cold compresses. Switched to Zyrtec and Prelone.
Headache for 5 days, beginning 10/19/11. Headache is mostly frontal, some occipital. No aura. Some nausea. Slight relief with ADVIL, EXCEDRIN, TYLENOL with Codeine in ER - complete relief but returned.
Hives 2 days after vax, Treated with Benadryl after taking baby to ER. Onset of rash 2 days post vax.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot #L012479, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Client given vaccine at 2:00pm and went to waiting area. Around 2:15pm, she felt unwell and notified staff. An EMT responded and caught her from falling out of the chair when she fainted. She was brought to medic station. VS at 2:18pm HR96, BP 118/86, O2 97% on RA. She was given water and an ice pack and started feeling better. Client left at 2:30pm, stating that she felt 'normal'.
Initial report received from a health care provider on 25-OCT-2005. A cluster of approximately ten patients experienced a "dark dot" at the injection site after receiving an intramuscular deltoid injection of FLUZONE, either lot number U1819AA or U1824AA, on an unknown date. The patients' ages, names, and dates of birth were not reported. Per the reporter, the small dark dot didn't wipe off. She then noticed residual on the vial stopper after prepping the vial with an alcohol swab. The vaccine administrator felt the residue was on the needle after penetrating the vial stopper, and this is what left the dark mark at the injection site. This occurred in approximately ten patients out of 1000 patients immunized. They use Precision Glide syringes with 23 gauge one inch needles. None of the patients reported an adverse event. The status of the patients' "dark dot" was not reported.
PER PATIENT'S WIFE, HE HAD REDNESS FROM HIS ELBOW TO HIS NECK AND WAS SWOLLEN. PATIENT WENT TO ED TO GET TREATMENTS. HE WAS IN PAIN
Dnr has redness and swelling to arm, warm to the touch at injection site and surrounding area occured approx 9pm.
A little over 4 weeks after getting my 2nd Pfizer Covid-19 vaccine I came down with ophthalmic herpes zoster (Shingles of the eye).  Symptoms started May 16 with a headache, followed the next days by a red eye, eye pain, severe headache, and rash started to appeared May 19. I was officially diagnosed on May 20th after seeing many multiple healthcare providers starting May 18th.  I was asked by a few doctor's I saw in the process of being diagnosed if I had recently received my covid vaccine. This lead me to think their might be a connection and that I should report this to VAERS in case.  I am still on medication for the ophthalmic herpes zoster as of today, July 8th.
A presently 19-month-old child experienced a febrile illness, fussiness, and limpness within 4 days after receipt of 2 month vaccines. The child had a negative rule-out sepsis work-up in 2013, and he had a history of GERD, and while he was feeding in the hospital, he had an acute life threatening event (ALTE) [oxygen desaturation to the 50s and limpness]; he was transferred to another hospital for subspecialty evaluations, had another ALTE there associated with feeding, but tests were negative, the child was d/c to home with apnea monitor and GERD precautons, and he has grown well since that time. The now 19- month-old child has not received any subsequent vaccines.  The parents and pediatrician would now like to begin vaccinating this male child, but they are very concerned because an older female sibling of this child died in 2009, within days after receiving routine 4 month vaccines.  Reportedly, the older sister developed upper respiratory congestion, limpness, was taken to the ED, went into respiratory arrest and died.
Severe body and muscle aches and pains exhaustion severe shakes & unable to sleep or move normally throughout the ate fever Symptoms lasted 3 days
Joints were locked, high fever (102), tightness in the chest, difficulty breathing, chest pain.
ACHES; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included allergic to penicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of aches was not reported. This report was non-serious. This case, from the same reporter is linked to 20210347232.